Kyrgyzstan: Aravan Cement Plant, part of the Southern Combine of Building Materials, is considering building a third production line with a capacity of 1.5Mt/yr. Plant director Kubanychbek Turdubaev made the announcement to Kyrgyzstan Newsline in a discussion reflecting on the completion of the unit’s second line in 2018, which increased total capacity to 1Mt/yr. The Russian-Kyrgyz Development Fund (RKDF) provided a loan for that project and the company intends to continue the relationship for the next one. China-based Tianjin Cement Industry Design and Research Institute (Sinoma TCDRI) and the Nanjing Long-W Energy Conservation Engineering were also involved. At present the plant sells half of its cement domestically and exports the rest.

Turkey: DAL Teknik Makina says that Çimsa Çimento has engaged its services for a cyclone replacement at its 3.4Mt/yr Mersin cement plant in Mersin Province. The upgrade consists of “modification of the first and second-stage cyclones and riser ducts in the first clinker production line, downcomer ducts modification, dip tubes, pendulum flaps, meal pipes and splash boxes installation and refractory procurement and installation.”

The group said, “The modification project will allow electrical and a small amount of heat energy reduction by reducing pressure drop and improving separation efficiency of the cyclones.”

Egypt: Egyptian Cement Group’s chief executive officer (CEO) Ahmed Abou Hashima says that the company plans to inaugurate its new cement factory in 2021. The plant is located in Sohag and has a total investment cost of US$285m, according to the Hapi Journal. The 2Mt/yr project was originally scheduled to open in the first half of 2020 but was delayed due to the coronavirus pandemic.

Nigeria: Lafarge Africa has made a donation of US$1.29m to the battle against Covid-19 in Nigeria. Business Day news has reported that the money will go towards “various initiatives aimed at fighting the pandemic.” Lafarge Africa previously gave the use of three of its facilities and donated personal protective equipment (PPE) for the isolation and treatment of Coronavrius patients in April 2020.